The Effect Of Chronic Use Of Antipsychotics On The Bone, Breast and Cervix -

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Klinik Psikofarmakoloji Bulteni-bulletin of Clinical Psychopharmacology

• Publication date

  2011-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.5455/BCP.20110510114010
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Are women with psychosis receiving adequate cervical cancer screening?

  2010cited by this paper
• Overcoming the barriers to HPV vaccination in high-risk populations in the US.

  2010cited by this paper
• Bone mineral density in schizophrenia patients on antipsychotics

  2009cited by this paper
• Osteoporosis Prevention and Management: An Evidence-based Review

  2008cited by this paper
• Antipsychotic drugs inhibit the function of breast cancer resistance protein.

  2008cited by this paper
• A crossover study of prolactin changes associated with risperidone and olanzapine.

  2006cited by this paper
• Cancer risk among users of neuroleptic medication: a population-based cohort study

  2006cited by this paper
• Prevalence of bone mineral density loss in Korean patients with schizophrenia: a cross-sectional study.

  2006cited by this paper
• Osteoporosis in patients with schizophrenia.

  2005cited by this paper
• Cancer in schizophrenia: is the risk higher or lower?

  2005cited by this paper
• Bone Mineral Density and Its Relationship to Prolactin Levels in Patients Taking Antipsychotic Treatment

  2005cited by this paper
• Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism.

  2004cited by this paper
• Effects of elevated serum prolactin on bone mineral density and bone metabolism in female patients with schizophrenia: a prospective study.

  2003cited by this paper
• Clozapine, Olanzapine, Risperidone, and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective Disorder

  2002cited by this paper
• Diagnosis of osteoporosis and assessment of fracture risk.

  2002cited by this paper
• Dopamine antagonists and the development of breast cancer.

  2002cited by this paper
• CLASSICAL AND ATYPICAL NEUROLEPTICS, AND BONE MINERAL DENSITY, IN PATIENTS WITH SCHIZOPHRENIA

  2002cited by this paper
• Risk of Breast Cancer According to Use of Antidepressants, Phenothizaines, and Anthistamines

  1999cited by this paper
• Effects of psychotropic drugs on cell proliferation and differentiation.

  1999cited by this paper
• Comparison of two Hologic DXA systems (QDR 1000 and QDR 4500/A).

  1997cited by this paper
• Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhea.

  1992cited by this paper
• Osteoporosis in men with hyperprolactinemic hypogonadism.

  1986cited by this paper
• Decreased bone density in hyperprolactinemic women.

  1980cited by this paper
• Breast cancer at a psychiatric hospital before and after the introduction of neuroleptic agents.

  1978cited by this paper
• Prior psychiatric treatment and the development of breast cancer.

  1978cited by this paper

• The incidence risk of gynecological cancer by antipsychotic use: a meta-analysis of 50,402 patients

  2024cites this paper
• Lower Bone Mineral Density at the Hip and Lumbar Spine in People with Psychosis Versus Controls: a Comprehensive Review and Skeletal Site-Specific Meta-analysis

  2016cites this paper
• Asenapine : A Novel Hope in the Treatment of Schizophrenia and Manic and Mixed Episodes of Bipolar I Disorder

  2013cites this paper
• Asenapine: A novel hope in the treatment of manic and mixed episodes of Bipolar I disorder -

  2013cites this paper